As of September 30, 2024, LanzaTech had $89.1 million in total cash, restricted cash, and investments, compared to total cash of $75.8 million at the end of second-quarter 2024. The sequential ...
Results from Phase 2a PET imaging target engagement trial published in the American Journal of Respiratory ... The decrease was primarily due to professional service expenses. Net loss of $57.8 ...